Market Knowledge Bob McGriff

More from the JPM Healthcare conference on the podcast with special guest Caitlin Tolman and Head of Life Sciences at Savills Austin Barrett.

Caitlin has spent years working with Life Sciences VCs and founders helping them navigate the everchanging fundraising climates.

In the conversation we talk about why JPM conference is the best time to begin the fundraising conversations with investors and the “new normal” when it comes to the raising capital in 2023.

This week on the podcast we are in San Francisco at the 41st JP Morgan Healthcare conference talking with Jonathan Norris, Managing Director at SVB Life Sciences, and Austin Barrett , Head of Life Sciences at Savills.

In the conversation we discuss the sights and sounds coming from the conference, a look back at Life Science funding in 2022,  and we get an inside look at the health of the industry with the author of Silicon Valley Bank’s Annual Healthcare Venture Report.

Jon also has some tips for Life Science companies seeking new funding,  and some predictions for 2023.

This week on the podcast we have the CEO and Founder of A28 Therapeutics Dr. Stanley T. Lewis.

A28 Therapeutics is a clinical-stage biopharmaceutical company focused on a new and very unique

platform to treat multiple cancer types.

In our discussion Dr. Lewis tells us about the challenges of launching a company,  and the new skill sets he’s had to develop along the way.

Today on the podcast we hear from CEO & founder of Lynx Biosciences, Inc., Chorom Pak. A native to Southern California, Chorom chose to base her startup in San Diego because of the collaborative nature of the life science ecosystem, which many agree is unique to this market.

On this podcast episode we talk about the value of mentorship, choosing the right incubator program, scaling a startup, and more.

This week on the podcast we have Taryn Goode  - Head of Life Sciences at Connect.

Taryn works and the busy intersection of founders and access to capital.

At Connect she supports early stage Life Science innovators and is deeply invested in the economic development of the San Diego region

On the podcast we learn more about Taryn and her experience making the transition from working at the lab bench to being a consultant to Life Science companies.

This week on the podcast we have Hugh Leslie, Life Science & Technology Practice Lead at Marsh McLennan Agency.

On the podcast we get Hugh’s thoughts on how the San Diego Life Science ecosystem encourages the creation on new companies.

We discuss the incredible growth of the industry over the past 20 years in San Diego, the current lab space real estate market, and much more.